Journal
VACCINE
Volume 28, Issue 12, Pages 2363-2366Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2009.12.084
Keywords
Adjuvant; Immunopotentiator; Delivery system; Vaccine; Poverty-related infections; Neglected infectious disease
Categories
Funding
- European Commission
Ask authors/readers for more resources
The workshop on vaccine adjuvants was held in July of 2009 at the European Commission in Brussels, with the goal of identifying key scientific priorities as they pertain to the development of effective vaccines against life-threatening diseases especially those associated with poverty, including HIV/AIDS, malaria and tuberculosis as well as neglected infectious diseases. On the basis of new advances in adjuvant research and related technology as well as potential challenges and roadblocks, six priorities were identified to accelerate development of improved or novel vaccine adjuvants for human use.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available